Do Not Add Lexapro to Mirtazapine in This Patient
Before adding escitalopram, you should first optimize the mirtazapine dose to 15-45 mg, as the current 7.5 mg dose is subtherapeutic for both depression and PTSD. If PTSD is confirmed, prioritize trauma-focused psychotherapy over pharmacotherapy, and if medication is needed for PTSD, switch to paroxetine, sertraline, or venlafaxine rather than adding escitalopram 1.
Key Clinical Issues to Address
1. Subtherapeutic Mirtazapine Dosing
- Current dose of 7.5 mg is below the therapeutic range for major depressive disorder (15-45 mg daily) 2
- At 7.5 mg, mirtazapine primarily provides sedation through antihistamine effects without adequate antidepressant action
- Increase to at least 15 mg daily before considering additional agents
- Mirtazapine shows efficacy for anxiety symptoms in depression and may have augmentation potential in PTSD 3
2. Establish a Formal PTSD Diagnosis
The patient reports military PTSD without documented diagnosis. You need to:
- Use structured assessment tools (Clinician-Administered PTSD Scale or similar)
- Differentiate between primary depression, primary PTSD, or comorbid conditions
- This distinction fundamentally changes treatment approach
3. Treatment Hierarchy Based on Diagnosis
If Primary PTSD (with depressive symptoms):
- First-line: Trauma-focused psychotherapy (prolonged exposure, cognitive processing therapy, or EMDR) - this is a strong recommendation over pharmacotherapy 1
- If pharmacotherapy needed: Switch to paroxetine, sertraline, or venlafaxine - these are the only antidepressants with strong evidence for PTSD 1
- Escitalopram is NOT recommended in VA/DoD guidelines for PTSD despite some open-label data 4, 5
- Mirtazapine can be used as augmentation to SSRIs in PTSD but not as monotherapy 3, 6
If Primary Depression (with trauma history):
- Optimize mirtazapine to 15-45 mg first
- If inadequate response after 4-6 weeks at therapeutic dose, consider switching rather than adding
- Escitalopram could be considered as a switch option for depression in elderly patients, though evidence is mixed 7, 8
Why Not Add Escitalopram Now?
Pharmacological Concerns:
- Serotonin syndrome risk: Both mirtazapine and escitalopram increase serotonergic activity 2, 9
- Polypharmacy in elderly: 77-year-old patients are at higher risk for drug interactions and adverse effects
- QTc prolongation: Both agents can prolong QTc interval; combination increases risk 2
- No evidence base: Escitalopram is not guideline-recommended for PTSD 1, 5, and adding it to subtherapeutic mirtazapine lacks rationale
Clinical Strategy Issues:
- You haven't optimized the first medication yet
- Adding agents before optimizing creates confusion about what's working
- In elderly patients, sequential monotherapy is preferred over combination therapy
Recommended Algorithm
Step 1: Increase mirtazapine to 15 mg for 2 weeks, then 30 mg if tolerated
- Monitor for weight gain, sedation, increased appetite 2
- Assess response at 4-6 weeks
Step 2: Formally assess for PTSD using validated tools
- If PTSD confirmed: Refer for trauma-focused psychotherapy (can use telehealth) 1
- If psychotherapy unavailable/refused: Switch to paroxetine 20 mg or sertraline 50-200 mg 1
Step 3: If inadequate response to optimized mirtazapine and primary diagnosis is depression:
- Switch to different antidepressant (sertraline, venlafaxine) rather than add
- Consider mirtazapine augmentation only if partial response to SSRI/SNRI
Step 4: If PTSD with partial response to guideline-recommended SSRI:
- Then consider adding mirtazapine as augmentation 3
Critical Pitfalls to Avoid
- Don't treat presumed PTSD without formal diagnosis - treatment algorithms differ significantly
- Don't use benzodiazepines - contraindicated in PTSD despite common use 1, 5
- Don't skip psychotherapy - it's more effective than medication for PTSD 1
- Don't combine antidepressants in elderly without optimizing monotherapy first
- Don't use escitalopram as first-line for PTSD - it lacks guideline support despite some positive open-label data 4, 5
The evidence strongly suggests that adding escitalopram 5 mg to subtherapeutic mirtazapine 7.5 mg is premature and potentially harmful. Optimize what you have, clarify the diagnosis, and follow evidence-based treatment hierarchies.